← Back to Search

Antibiotic

Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn

N/A
Waitlist Available
Led By Anne Lachiewicz, MD, MPH
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1. Severe burn injury, including partial or full thickness burn 20% or more total body surface area; or 2. inhalation injury; or 3. 18 years of age or older;
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from hospital admission until discharge from unit, or date of death from any cause (assessed up to 1 year)
Awards & highlights
No Placebo-Only Group

Summary

This is a prospective observational study to determine the role of colonization and identify the timing of development of drug resistance in multidrug resistant Gram-negative bacilli (MDR-GNB) causing infection among critically ill burn patients.

Eligible Conditions
  • Gram-Negative Bacteria Colonization

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from hospital admission until discharge from unit, or date of death from any cause (assessed up to 1 year)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from hospital admission until discharge from unit, or date of death from any cause (assessed up to 1 year) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Species causing MDR-GNB colonization
Time to MDR-GNB colonization
Time to VAT/VAP
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Burn patients with VAT or VAP with MDR-GNBExperimental Treatment1 Intervention
Adult patients with burn and/or inhalation injury requiring intubation

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,569 Previous Clinical Trials
4,319,659 Total Patients Enrolled
North Carolina Translational and Clinical Sciences InstituteOTHER
59 Previous Clinical Trials
4,410 Total Patients Enrolled
Anne Lachiewicz, MD, MPHPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top